Georgetown, TX, United States of America

Nadav Friedman


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nadav Friedman: Innovator in Opioid Antagonism

Introduction

Nadav Friedman is an accomplished inventor based in Georgetown, TX, known for his innovative contributions in the field of pharmaceuticals. With one patent to his credit, Friedman has made significant strides in addressing critical issues related to opioid use and abuse.

Latest Patents

Friedman's notable patent is for a unique 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal. This invention serves as an opioid antagonist, revealing a groundbreaking therapeutic approach. It also involves a drug-in-adhesive transdermal patch that contains fentanyl, a mu opioid agonist, combined with the cocrystal to effectively manage pain. The tamper-resistant patch is designed to deter drug misuse or abuse, offering a safer alternative for patients requiring pain management. The patent encompasses methods for treating various pain types, including acute, chronic, or intermittent pain, highlighting the versatility and efficacy of this innovative delivery system.

Career Highlights

Friedman is currently associated with Pain Therapeutics, Inc., a company focused on developing innovative solutions for pain management. Throughout his career, he has been dedicated to creating effective treatments that balance pain relief with safety, reflecting his commitment to improving patient outcomes in the face of the ongoing opioid crisis.

Collaborations

In his professional journey, Nadav Friedman has collaborated with fellow innovators such as Remi Barbier and Vijay Srirambhatla. These partnerships have not only enhanced his work but also contributed to the development of safe and effective therapeutic options within the industry.

Conclusion

Nadav Friedman is an influential inventor whose work in opioid antagonism and pain management continues to have a significant impact. His innovative patent represents a crucial advancement in the healthcare sector, addressing the pressing need for safer pain relief options. As he continues to collaborate and innovate, Friedman's contributions will undoubtedly play a pivotal role in enhancing patient care and combating opioid misuse.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…